Observational studyBMC pregnancy and childbirth2026
Prenatal ultrasound findings associated with intrauterine CMV infection: a multicenter retrospective analysis of clinical and sonographic features.
Observational study in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cysteine-based molecular switches: a focus on KEAP1 and BACH1 in regulating the antioxidant response.Archives of toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo assess the association between prenatal ultrasonography and intrauterine Cytomegalovirus (CMV) infection and to elucidate its clinical characteristics.
methodsCases were selected from three medical centers (2015-2024) in which amniotic fluid CMV-DNA testing was performed following prenatal ultrasound findings suggestive of CMV infection. CMV infection rates were analyzed in relation to distinct sonographic abnormalities. Associations between amniotic fluid viral load, imaging characteristics, and pregnancy outcomes were subsequently evaluated.
resultsAmong 1,174 pregnant women, 45 (3.83%) tested positive for CMV‑DNA in amniotic fluid. Sonographic findings with CMV infection rates exceeding 50% included fetal intracranial hyperechogenicity, intraventricular adhesions, hepatosplenomegaly, and placental thickening. The infection rate was significantly higher in fetuses with multiple abnormalities (10.42%) than with isolated findings (2.14%) (P<0.001). Combined intracranial and extracranial abnormalities carried a higher infection rate (13.41%) than purely intracranial (3.28%) or purely extracranial (2.76%) abnormalities (P<0.001). In CMV‑positive cases, amniotic fluid VL ranged from 1.1 × 10² to 7.71 × 10⁷ copies/mL (median 3.86 × 10⁵ copies/mL). VL was significantly elevated in cases with intracranial, severe, or non‑isolated abnormalities (P<0.05). Of 14 cases tested for cord blood CMV‑IgM, 10 (71.43%) were positive; intracranial abnormalities were present in 8 of these, but in none of the IgM‑negative cases. Maternal CMV‑IgM was positive in only 2/19 (10.53%) infected cases. Pregnancy was terminated in 25 cases; among 13 live‑born infants with follow‑up, 9 had normal outcomes, 3 had hearing impairment, and 1 had severe neurological sequelae.
conclusionsSpecific prenatal ultrasound findings show a high rate of association with intrauterine CMV infection, especially when there are multiple abnormalities or when abnormalities involve both the intracranial and extracranial compartments. Amniotic fluid CMV-DNA load correlates positively with the presence of intracranial abnormalities and overall severity of ultrasound findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.